DEFINITIVE 1998 PROXY MATERIALS

Company

Ernexa Therapeutics Inc.

Filed

July 31, 1998

Period of Report

August 28, 1998

Accession Number

0001035704-98-000450

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →